Literature DB >> 15475007

P27 expression is regulated by separate signaling pathways, downstream of Ras, in each cell cycle phase.

Gaurisankar Sa1, Dennis W Stacey.   

Abstract

The cyclin inhibitory protein p27Kip1 (p27) plays a vital role in regulating cell proliferation in response to the extracellular growth environment. Active proliferation requires the suppression of p27 levels throughout the cell cycle. Late in the cell cycle, p27 degradation requires phosphorylation of Thr 187 by cyclin dependent kinase 2, leading to recognition by the SCF ubiquitin ligase containing the Skp2 F-box protein. Suppression of p27 is also essential for cell proliferation early in the cell cycle, but this occurs independently of Skp2, whose expression is suppressed during G1 phase. In this study, we use a time lapse and quantitative imaging approach to study the connection between proliferative signaling and the degradation of p27 during each cell cycle period in actively cycling cells. Ras activity was required for the suppression of p27 levels throughout the cell cycle, but separate pathways downstream of Ras signaling were required in different cell cycle periods. For example, inhibitors of MEK and phosphatidylinositol-3-kinase induced p27 expression primarily in G1 phase, while inhibitors of AKT activity stimulated these levels primarily in S phase. Skp2 was expressed in a Ras-dependent manner at higher levels late in the cell cycle. Its ablation resulted in higher p27 levels primarily in G2 phase as expected. The fact that separate signaling pathways downstream of Ras function in each cell cycle phase to suppress p27 levels helps explain the vital connection between proliferative signaling, cell cycle control, and p27 expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15475007     DOI: 10.1016/j.yexcr.2004.07.032

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  20 in total

1.  Ras Signaling in Breast Cancer.

Authors:  Aree Moon
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Platelet-rich plasma increases proliferation of tendon cells by modulating Stat3 and p27 to up-regulate expression of cyclins and cyclin-dependent kinases.

Authors:  T-Y Yu; J-H S Pang; K P-H Wu; L-P Lin; W-C Tseng; W-C Tsai
Journal:  Cell Prolif       Date:  2015-05-25       Impact factor: 6.831

3.  Focal adhesion kinase controls cellular levels of p27/Kip1 and p21/Cip1 through Skp2-dependent and -independent mechanisms.

Authors:  Patrick Bryant; Qingxia Zheng; Kevin Pumiglia
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

4.  Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals.

Authors:  Yaara Zwang; Aldema Sas-Chen; Yotam Drier; Tal Shay; Roi Avraham; Mattia Lauriola; Efrat Shema; Efrat Lidor-Nili; Jasmine Jacob-Hirsch; Ninette Amariglio; Yiling Lu; Gordon B Mills; Gideon Rechavi; Moshe Oren; Eytan Domany; Yosef Yarden
Journal:  Mol Cell       Date:  2011-05-20       Impact factor: 17.970

5.  Three Observations That Have Changed Our Understanding of Cyclin D1 and p27 in Cell Cycle Control.

Authors:  Dennis W Stacey
Journal:  Genes Cancer       Date:  2010-12

Review 6.  RAS oncogenes: weaving a tumorigenic web.

Authors:  Yuliya Pylayeva-Gupta; Elda Grabocka; Dafna Bar-Sagi
Journal:  Nat Rev Cancer       Date:  2011-10-13       Impact factor: 60.716

7.  Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumours.

Authors:  B Nitzsche; C Gloesenkamp; M Schrader; M Ocker; R Preissner; M Lein; A Zakrzewicz; B Hoffmann; M Höpfner
Journal:  Br J Cancer       Date:  2010-06-15       Impact factor: 7.640

8.  Targeting of the Akt-nuclear factor-kappa B signaling network by [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a novel indole-3-carbinol derivative, in a mouse model of hepatocellular carcinoma.

Authors:  Hany A Omar; Aaron M Sargeant; Jing-Ru Weng; Dasheng Wang; Samuel K Kulp; Tushar Patel; Ching-Shih Chen
Journal:  Mol Pharmacol       Date:  2009-08-25       Impact factor: 4.436

9.  OSU-A9, a potent indole-3-carbinol derivative, suppresses breast tumor growth by targeting the Akt-NF-kappaB pathway and stress response signaling.

Authors:  Jing-Ru Weng; Chen-Hsun Tsai; Hany A Omar; Aaron M Sargeant; Dasheng Wang; Samuel K Kulp; Charles L Shapiro; Ching-Shih Chen
Journal:  Carcinogenesis       Date:  2009-08-25       Impact factor: 4.944

10.  Inhibition of PI-3K restores nuclear p27Kip1 expression in a mouse model of Kras-driven lung cancer.

Authors:  K S Kelly-Spratt; J Philipp-Staheli; K E Gurley; K Hoon-Kim; S Knoblaugh; C J Kemp
Journal:  Oncogene       Date:  2009-08-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.